188 related articles for article (PubMed ID: 18853344)
41. Targeting NF-kappaB: a promising molecular therapy in inflammatory arthritis.
Roman-Blas JA; Jimenez SA
Int Rev Immunol; 2008; 27(5):351-74. PubMed ID: 18853343
[TBL] [Abstract][Full Text] [Related]
42. Sensitization of endothelial cells to VEGI-induced apoptosis by inhibiting the NF-kappaB pathway.
Grimaldo S; Tian F; Li LY
Apoptosis; 2009 Jun; 14(6):788-95. PubMed ID: 19418226
[TBL] [Abstract][Full Text] [Related]
43. Targeting NF-kappa B with a natural triterpenoid alleviates skin inflammation in a mouse model of psoriasis.
Wang H; Syrovets T; Kess D; Büchele B; Hainzl H; Lunov O; Weiss JM; Scharffetter-Kochanek K; Simmet T
J Immunol; 2009 Oct; 183(7):4755-63. PubMed ID: 19752240
[TBL] [Abstract][Full Text] [Related]
44. Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes.
Checker R; Sharma D; Sandur SK; Khanam S; Poduval TB
Int Immunopharmacol; 2009 Jul; 9(7-8):949-58. PubMed ID: 19374955
[TBL] [Abstract][Full Text] [Related]
45. [Effects of early insulin therapy on nuclear factor kappaB pathway in skeletal muscle of diabetes: experiment with rats].
Bi Y; Sun WP; Chen X; Cai MY; Liang H; Zhu YH; He XY; Yu QQ; Li M; Weng JP
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(46):3287-92. PubMed ID: 19159557
[TBL] [Abstract][Full Text] [Related]
46. Xenobiotic receptor meets NF-kappaB, a collision in the small bowel.
Xie W; Tian Y
Cell Metab; 2006 Sep; 4(3):177-8. PubMed ID: 16950133
[TBL] [Abstract][Full Text] [Related]
47. In this issue: basic immunology and translational research on NF-kappaB.
Bot A
Int Rev Immunol; 2008; 27(5):283-5. PubMed ID: 18853339
[No Abstract] [Full Text] [Related]
48. The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation.
Tornatore L; Thotakura AK; Bennett J; Moretti M; Franzoso G
Trends Cell Biol; 2012 Nov; 22(11):557-66. PubMed ID: 22995730
[TBL] [Abstract][Full Text] [Related]
49. NF-kappaB signaling: a tale of two pathways in skeletal myogenesis.
Bakkar N; Guttridge DC
Physiol Rev; 2010 Apr; 90(2):495-511. PubMed ID: 20393192
[TBL] [Abstract][Full Text] [Related]
50. A role for transcription factor NF-kappaB in autoimmunity: possible interactions of genes, sex, and the immune response.
Dale E; Davis M; Faustman DL
Adv Physiol Educ; 2006 Dec; 30(4):152-8. PubMed ID: 17108242
[TBL] [Abstract][Full Text] [Related]
51. The two-faced NF-kappaB in the skin.
Sur I; Ulvmar M; Toftgård R
Int Rev Immunol; 2008; 27(4):205-23. PubMed ID: 18574737
[TBL] [Abstract][Full Text] [Related]
52. NF-kappaB signaling in skeletal muscle: prospects for intervention in muscle diseases.
Mourkioti F; Rosenthal N
J Mol Med (Berl); 2008 Jul; 86(7):747-59. PubMed ID: 18246321
[TBL] [Abstract][Full Text] [Related]
53. Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration.
Mourkioti F; Kratsios P; Luedde T; Song YH; Delafontaine P; Adami R; Parente V; Bottinelli R; Pasparakis M; Rosenthal N
J Clin Invest; 2006 Nov; 116(11):2945-54. PubMed ID: 17080195
[TBL] [Abstract][Full Text] [Related]
54. Tumor promoting or tumor suppressing of NF-kappa B, a matter of cell context dependency.
Chen F; Beezhold K; Castranova V
Int Rev Immunol; 2008; 27(4):183-204. PubMed ID: 18574736
[TBL] [Abstract][Full Text] [Related]
55. [Role of mineral elements in the immunological effects, activation nuclear transcription factor of NF-kappaB and matrix metalloproteinase].
Turna AA; Devichenskiĭ VM
Vopr Pitan; 2010; 79(2):66-72. PubMed ID: 20560488
[TBL] [Abstract][Full Text] [Related]
56. The TRAF6-NF kappa B signaling pathway in autoimmunity: not just inflammation.
Thomas R
Arthritis Res Ther; 2005; 7(4):170-3. PubMed ID: 15987501
[No Abstract] [Full Text] [Related]
57. Transcription Factor NF-κB: An Update on Intervention Strategies.
Panday A; Inda ME; Bagam P; Sahoo MK; Osorio D; Batra S
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(6):463-483. PubMed ID: 27236331
[TBL] [Abstract][Full Text] [Related]
58. NF-kappaB signaling pathways in mammalian and insect innate immunity.
Silverman N; Maniatis T
Genes Dev; 2001 Sep; 15(18):2321-42. PubMed ID: 11562344
[No Abstract] [Full Text] [Related]
59. New regulators of NF-kappaB in inflammation.
Ghosh S; Hayden MS
Nat Rev Immunol; 2008 Nov; 8(11):837-48. PubMed ID: 18927578
[TBL] [Abstract][Full Text] [Related]
60. VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects.
Heier CR; Damsker JM; Yu Q; Dillingham BC; Huynh T; Van der Meulen JH; Sali A; Miller BK; Phadke A; Scheffer L; Quinn J; Tatem K; Jordan S; Dadgar S; Rodriguez OC; Albanese C; Calhoun M; Gordish-Dressman H; Jaiswal JK; Connor EM; McCall JM; Hoffman EP; Reeves EK; Nagaraju K
EMBO Mol Med; 2013 Oct; 5(10):1569-85. PubMed ID: 24014378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
